Nurse Practitioner, Family · Dartmouth, MA
NPI
1437668241
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
535 Faunce Corner Rd
Dartmouth, MA, 02747
Phone (508) 996-3991
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
2,683 services
Medicare patients, 2024
325
Average age 73
Drug cost, 2024
$4.0M
7,696 prescriptions
Company payments, 2025
$439
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joymon K Sebastian was code 99213 (office e&m - established), 593 times for 267 patients. In total Joymon K Sebastian billed 2,683 services in 36 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 593 | 267 | $53.28 | $32K |
| 82962 Clinical Chemistry | Office | 571 | 238 | $3.19 | $1,822 |
| 36415 Venipuncture Blood Collection | Office | 281 | 216 | $8.65 | $2,431 |
| 83036 Blood Count | Office | 249 | 198 | $9.48 | $2,361 |
| 99214 Office E&M - Established | Office | 212 | 122 | $68.90 | $15K |
| 80053 Clinical Chemistry | Office | 209 | 166 | $10.30 | $2,153 |
| 84443 Clinical Chemistry | Office | 84 | 68 | $15.93 | $1,338 |
| 82043 Clinical Chemistry | Office | 76 | 71 | $5.66 | $430 |
| 82570 Clinical Chemistry | Office | 76 | 71 | $5.08 | $386 |
| 82607 Clinical Chemistry | Office | 64 | 60 | $14.55 | $931 |
| 80061 Clinical Chemistry | Office | 30 | 27 | $13.12 | $394 |
| 84439 Clinical Chemistry | Office | 21 | 16 | $8.48 | $178 |
| 80048 Clinical Chemistry | Office | 19 | 16 | $8.29 | $158 |
By year: 2022 $93K for 4,549 services; 2023 $88K for 4,287 services; 2024 $62K for 2,683 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 571 | 238 | $3.19 | $1,822 |
| 36415 Venipuncture Blood Collection | 281 | 216 | $8.65 | $2,431 |
| 83036 Blood Count | 249 | 198 | $9.48 | $2,361 |
| 80053 Clinical Chemistry | 209 | 166 | $10.30 | $2,153 |
| 84443 Clinical Chemistry | 84 | 68 | $15.93 | $1,338 |
| 82570 Clinical Chemistry | 76 | 71 | $5.08 | $386 |
| 82043 Clinical Chemistry | 76 | 71 | $5.66 | $430 |
| 82607 Clinical Chemistry | 64 | 60 | $14.55 | $931 |
| 80061 Clinical Chemistry | 30 | 27 | $13.12 | $394 |
| 84439 Clinical Chemistry | 21 | 16 | $8.48 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Joymon K Sebastian prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 889 prescriptions and refills. In total Joymon K Sebastian wrote 7,696 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 889 | 1,163 | 161 | $1.1M |
| Jardiance Empagliflozin | 653 | 1,379 | 163 | $784K |
| Metformin Hcl Generic | 583 | 1,469 | 163 | $5,459 |
| Levothyroxine Sodium Generic | 385 | 960 | 117 | $5,392 |
| Ozempic Semaglutide | 381 | 540 | 79 | $494K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 370 | 692 | 108 | $45K |
| Metformin Hcl Er Metformin Hcl | 321 | 798 | 92 | $3,102 |
| Glipizide Generic | 286 | 747 | 88 | $2,351 |
| Mounjaro Tirzepatide | 270 | 296 | 57 | $305K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 213 | 456 | 81 | $18K |
| Januvia Sitagliptin Phosphate | 187 | 402 | 53 | $214K |
| Glipizide Er Glipizide | 163 | 394 | 45 | $2,465 |
| Farxiga Dapagliflozin Propanediol | 148 | 314 | 37 | $172K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 146 | 230 | 35 | $39K |
| Methimazole Generic | 145 | 331 | 35 | $1,364 |
Brand drugs: 4,449 claims; generic drugs: 2,541 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joymon K Sebastian $439 ($439 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $142.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.